Some leading AstraZeneca Plc shareholders were at odds over whether the British drugmaker made the right decision in rejecting Pfizer Inc's final $118 billion bid to purchase the company.Schroder Investment Management Ltd, AstraZeneca's 12th-biggest shareholder, urged the drugmaker on Tuesday to restart takeover talks with Pfizer while Fidelity Worldwide Investment (UK) Ltd, holder of the 18th largest stake in Astra, backed the British company's stance.The division highlighted a split among investors following the collapse of a potential transaction, leaving many shareholders frustrated at missing out on a big windfall.Schroders said it was disappointed with "the quick rejection by the AstraZeneca board" of an improved 55 pounds-a-share offer and the decision by Pfizer to "draw a premature end to these negotiations by calling their latest proposal final."
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN traded higher by 2.17% or $1.53/share to $72.17. In the past year, the shares have traded as low as $46.87 and as high as $82.68. On average, 4557230 shares of AZN exchange hands on a given day and today's volume is recorded at 12122950.
Source
